Context matters: hepatitis C is now curable — modern direct-acting antivirals clear the virus in over 95% of patients in weeks, with mild side effects. The old rationale for cannabis (enduring brutal year-long interferon regimens) is mostly history. If you have untreated HCV, the medical priority is antiviral treatment, full stop; no cannabis question outranks it.
Where cannabis still fits: symptom support during treatment for the minority with harder courses, and management of conditions that travel with HCV (chronic pain, sleep, anxiety). One liver-specific note: heavy daily cannabis use has been studied for fibrosis effects with mixed findings — patients with significant liver disease should keep their hepatologist in the loop and favor moderate, non-smoked use.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law.